Copeland Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-149
| Closed | -$31.9K | – | 287 |
|
|
2025
Q1 | $33.4K | Sell |
149
-3,011
| -95% | -$830K | ﹤0.01% | 212 |
|
|
2024
Q4 | $1.04M | Sell |
3,160
-136
| -4% | -$42.8K | 0.02% | 127 |
|
|
2024
Q3 | $989K | Sell |
3,296
-91
| -3% | -$27.9K | 0.02% | 132 |
|
|
2024
Q2 | $1.12M | Sell |
3,387
-112
| -3% | -$39.6K | 0.02% | 128 |
|
|
2024
Q1 | $1.38M | Sell |
3,499
-82
| -2% | -$30.3K | 0.03% | 122 |
|
|
2023
Q4 | $1.26M | Buy |
3,581
+226
| +7% | +$80K | 0.03% | 116 |
|
|
2023
Q3 | $1.26M | Sell |
3,355
-73
| -2% | -$28.2K | 0.03% | 119 |
|
|
2023
Q2 | $1.31M | Sell |
3,428
-718
| -17% | -$256K | 0.03% | 118 |
|
|
2023
Q1 | $1.44M | Sell |
4,146
-73
| -2% | -$21.3K | 0.03% | 114 |
|
|
2022
Q4 | $993K | Buy |
4,219
+3,751
| +801% | +$889K | 0.03% | 125 |
|
|
2022
Q3 | $115K | Buy |
468
+460
| +5,750% | +$140K | ﹤0.01% | 150 |
|
|
2022
Q2 | $2K | Hold |
8
| – | – | ﹤0.01% | 267 |
|
|
2022
Q1 | $3K | Hold |
8
| – | – | ﹤0.01% | 255 |
|
|
2021
Q4 | $4K | Sell |
8
-5
| -38% | -$2.15K | ﹤0.01% | 232 |
|
|
2021
Q3 | $6K | Hold |
13
| – | – | ﹤0.01% | 216 |
|
|
2021
Q2 | $5K | Hold |
13
| – | – | ﹤0.01% | 215 |
|
|
2021
Q1 | $4K | Hold |
13
| – | – | ﹤0.01% | 222 |
|
|
2020
Q4 | $4K | Hold |
13
| – | – | ﹤0.01% | 212 |
|
|
2020
Q3 | $4K | Hold |
13
| – | – | ﹤0.01% | 201 |
|
|
2020
Q2 | $3K | Hold |
13
| – | – | ﹤0.01% | 202 |
|
|
2020
Q1 | $2K | Hold |
13
| – | – | ﹤0.01% | 237 |
|
|
2019
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 264 |
|
|
2019
Q3 | $2K | Hold |
13
| – | – | ﹤0.01% | 260 |
|
|
2019
Q2 | $2K | Hold |
13
| – | – | ﹤0.01% | 261 |
|
|
2019
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 261 |
|
|
2018
Q4 | $1K | Buy |
+13
| New | +$1.41K | ﹤0.01% | 269 |
|
Other funds holding WST
